Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Degarelix freeze-dried powder injection for injection and preparation method thereof

A technology of freeze-dried powder injection, degarelix

Inactive Publication Date: 2018-02-16
天津双硕医药科技有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Some other organic solvents, such as ethanol, have low freezing points, and generally freeze at tens of degrees below zero. General freeze dryers cannot freeze and capture them, and eventually enter the vacuum pump, so they cannot be used in actual production.
[0021] ② The vapor pressure of tert-butanol is relatively high, which is conducive to sublimation and saves freeze-drying time, while another organic solvent, dimethyl sulfoxide, has a low vapor pressure and is difficult to sublimate, although its freezing point is 18.4°C. Difficult to freeze dry
Although cyclohexane can be frozen at room temperature (6.5°C), it is almost immiscible with water and can only be used for fat-soluble drugs, which greatly limits its application range

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Degarelix freeze-dried powder injection for injection and preparation method thereof
  • Degarelix freeze-dried powder injection for injection and preparation method thereof
  • Degarelix freeze-dried powder injection for injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] Example 1 Preparation of 80 mg degarelix freeze-dried preparation (unit: g)

[0097] prescription:

[0098]

[0099] The degarelix freeze-dried preparation is prepared through the following steps:

[0100]Step 1, take the prescribed amount of mannitol and trehalose, crush them, pass through a 100-mesh sieve, and set aside;

[0101] Step 2, take 80% of the prescribed amount of water for injection, and dissolve trehalose and mannitol in turn;

[0102] Step 3, add the tert-butanol of recipe quantity;

[0103] Step 4, under the condition of nitrogen protection, add the prescribed amount of degarelix acetate, stir slowly, and dissolve;

[0104] Step 5, add water for injection to the full amount, and adjust the pH;

[0105] Step 6, add 0.2% activated carbon to the liquid medicine obtained in step 5, and let it stand for 20 minutes to remove the pyrogen;

[0106] Step 7, step 6 obtained liquid medicine is filtered with 0.22um microporous membrane, twice;

[0107] Step...

Embodiment 2

[0113] Example 2 Preparation of 80 mg degarelix freeze-dried preparation (unit: g)

[0114] prescription:

[0115]

[0116] Preparation method, with embodiment 1.

Embodiment 3

[0117] Example 3 Preparation of 80 mg degarelix freeze-dried preparation (unit: g)

[0118] prescription:

[0119]

[0120] Preparation method, with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In the process of researching a degarelix freeze-dried preparation, the inventor finds that viscosity of a medicine-containing solution can be lowered effectively and gelation time can be prolonged byadding a certain amount of tertiary butanol into a water solution before freeze-drying, the inventor further finds that adding of trehalose is conducive to further prolonging the gelation time and improving long-time stability of the preparation. On this basis, a degarelix freeze-dried preparation prescription and process are developed and are simple, easy for quality control and suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a degarelix freeze-dried powder for injection and a preparation process thereof. Background technique [0002] In recent years, the incidence of prostate cancer has been increasing day by day, and it has become the male tumor type with the highest mortality rate. In 2006, the incidence rate in Europe was about 0.11%. In 2008, the incidence of prostate cancer in the United States was 186,320, and the death toll was 28,660, with a mortality rate of 15.4%. Studies have shown that testosterone levels are positively correlated with the proliferation rate of prostate cancer. If testosterone does not bind to the androgen receptor that can be expressed in most prostate cancer patients, cancer cells will undergo apoptosis. Both gonadotropin-releasing hormone (GnRH) receptor agonists and GnRH receptor antagonists can be used to control testosterone levels. [0003] Degarelix...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/19A61K38/09A61K47/26A61K47/10A61P13/08A61P35/00
CPCA61K9/0019A61K9/19A61K38/09A61K47/10A61K47/26
Inventor 不公告发明人
Owner 天津双硕医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products